Date Time
Constructing First Version of Japanese Reference Genome
The Japanese now have their own reference genome thanks to researchers at Tohoku University who completed and released the first Japanese reference genome (JG1).
Their study was published in the journal Nature Communications on January 11, 2021.
“JG1 can aid with the clinical sequence analysis of Japanese individuals with rare diseases as it eliminates the genomic differences from the international reference genome,” said Jun Takayama, co-author of the study.
Back in 2003, the Human Genome Project, through a gargantuan global effort, cracked the code of life and mapped all the genes of the human genome.
Published January 28. 2021 7:15PM | Updated January 28. 2021 9:30PM
Groton Groton school officials reported Thursday that they learned that members of the Northeast Academy and Fitch High School communities tested positive for COVID-19. Fortunately, there are no student or staff contacts in the schools due to the district operating this week in full distance learning, Groton Superintendent Susan Austin wrote in a notification. The affected individuals have been instructed to isolate at home following public health guidelines. Loading comment count.
As a business reporter, I write about small businesses opening and closing, manufacturing, food and drink, labor issues and economic data. I particularly love writing about the impact of state and federal policy on local businesses. I also do some education reporting, covering colleges in southeastern Connecticut and regional K-12 issues.
Erica Moser
As a business reporter, I write about small businesses opening and closing, manufacturing, food and drink, labor issues and economic data. I particularly love writing about the impact of state and federal policy on local businesses. I also do some education reporting, covering colleges in southeastern Connecticut and regional K-12 issues.
The chief of the state's Bureau of Infectious Disease Control joined WMUR on News 9 at 5:30 p.m. to answer viewer questions about the pandemic and the vaccines.
Professor Ron Quinn AM, Principal Research Leader at the Griffith Institute for Drug Discovery.
A new method of identifying molecular targets to fight disease could help accelerate future drug development new Griffith University research published in Scientific Reports has found.
“Even in this molecular era of drug discovery, there remain new investigational drugs whose molecular targets are unclear, restricting their optimisation and broad use in disease,” Professor Quinn said.
Protein 4J57 – “Plasmodium falciparum thioredoxin reductase-thioredoxin complex”
“A key step in the discovery of new pharmaceutical drugs and developing them to useful treatments for patients is, therefore, the identification of the molecular target while, at the same time, ensuring the drug does not interact with other gene products that would cause side effects.”